Queensland COVID-19 Vaccination (QoVAX) Safety and Efficacy Trial Program: Mixed Dose 1 and 2 Study
Latest Information Update: 11 Mar 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms QoVAX SET
- 04 Feb 2022 Status changed from not yet recruiting to recruiting.
- 12 Nov 2021 New trial record